New Predictors of Early and Late Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction and Unprotected Left Main Coronary Artery Culprit Lesion.


Journal

Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826

Informations de publication

Date de publication:
2019
Historique:
received: 02 09 2018
accepted: 04 03 2019
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 29 2 2020
Statut: epublish

Résumé

The study evaluated the correlation between baseline SYNTAX Score, Residual SYNTAX Score, and SYNTAX Revascularization Index and long-term outcomes in ST-elevation myocardial infarction (STEMI) patients with primary percutaneous coronary intervention (PCI) on an unprotected left main coronary artery lesion (UPLMCA). Previous studies on primary PCI in UPLMCA have identified cardiogenic shock, TIMI 0/1 flow, and cardiac arrest, as prognostic factors of an unfavourable outcome, but the complexity of coronary artery disease and the extent of revascularization have not been thoroughly investigated in these high-risk patients. 30-day, 1-year, and long-term outcomes were analyzed in a cohort of retrospectively selected, 81 consecutive patients with STEMI, and primary PCI on UPLMCA. Cardiogenic shock (p=0.001), age (p=0.008), baseline SYNTAX Score II (p=0.006), and SYNTAX Revascularization Index (p=0.046) were independent mortality predictors at one-year follow-up. Besides cardiogenic shock (HR 3.28, p<0.001), TIMI 0/1 flow (HR 2.17, p=0.021) and age (HR 1.03, p=0.006), baseline SYNTAX Score II (HR 1.06, p=0.006), residual SYNTAX Score (HR 1.03, p=0.041), and SYNTAX Revascularization Index (HR 0.9, p=0.011) were independent predictors of mortality at three years of follow-up. In patients with TIMI 0/1 flow, the presence of Rentrop collaterals was an independent predictor for long-term survival (HR 0.24; p=0.049). In this study, the complexity of coronary artery disease and the extent of revascularization represent independent mortality predictors at long-term follow-up.

Sections du résumé

OBJECTIVES OBJECTIVE
The study evaluated the correlation between baseline SYNTAX Score, Residual SYNTAX Score, and SYNTAX Revascularization Index and long-term outcomes in ST-elevation myocardial infarction (STEMI) patients with primary percutaneous coronary intervention (PCI) on an unprotected left main coronary artery lesion (UPLMCA).
BACKGROUND BACKGROUND
Previous studies on primary PCI in UPLMCA have identified cardiogenic shock, TIMI 0/1 flow, and cardiac arrest, as prognostic factors of an unfavourable outcome, but the complexity of coronary artery disease and the extent of revascularization have not been thoroughly investigated in these high-risk patients.
METHODS METHODS
30-day, 1-year, and long-term outcomes were analyzed in a cohort of retrospectively selected, 81 consecutive patients with STEMI, and primary PCI on UPLMCA.
RESULTS RESULTS
Cardiogenic shock (p=0.001), age (p=0.008), baseline SYNTAX Score II (p=0.006), and SYNTAX Revascularization Index (p=0.046) were independent mortality predictors at one-year follow-up. Besides cardiogenic shock (HR 3.28, p<0.001), TIMI 0/1 flow (HR 2.17, p=0.021) and age (HR 1.03, p=0.006), baseline SYNTAX Score II (HR 1.06, p=0.006), residual SYNTAX Score (HR 1.03, p=0.041), and SYNTAX Revascularization Index (HR 0.9, p=0.011) were independent predictors of mortality at three years of follow-up. In patients with TIMI 0/1 flow, the presence of Rentrop collaterals was an independent predictor for long-term survival (HR 0.24; p=0.049).
CONCLUSIONS CONCLUSIONS
In this study, the complexity of coronary artery disease and the extent of revascularization represent independent mortality predictors at long-term follow-up.

Identifiants

pubmed: 31772547
doi: 10.1155/2019/8238972
pmc: PMC6739789
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8238972

Informations de copyright

Copyright © 2019 Cãlin Homorodean et al.

Déclaration de conflit d'intérêts

None of the authors has any conflicts of interest to disclose.

Références

EuroIntervention. 2015 Oct;11(6):634-42
pubmed: 25308300
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Am Heart J. 2010 Dec;160(6):995-1003, 1003.e1-8
pubmed: 21146650
Int Heart J. 2013;54(4):185-91
pubmed: 23924928
Singapore Med J. 2016 Jul;57(7):396-400
pubmed: 27439434
Catheter Cardiovasc Interv. 2012 Jun 1;79(7):1111-6
pubmed: 22234952
Cardiol J. 2013;20(2):190-6
pubmed: 23558878
EuroIntervention. 2017 Mar 20;12(16):1995-2000
pubmed: 27973327
Circulation. 2007 May 1;115(17):2344-51
pubmed: 17470709
Circ J. 2008 Oct;72(10):1598-604
pubmed: 18762703
JACC Cardiovasc Interv. 2011 Jun;4(6):627-33
pubmed: 21700248
JACC Cardiovasc Interv. 2014 Sep;7(9):969-80
pubmed: 25234669
Catheter Cardiovasc Interv. 2015 Feb 15;85(3):416-20
pubmed: 25322922
JACC Cardiovasc Interv. 2013 Apr;6(4):317-24
pubmed: 23597607
J Interv Cardiol. 2012 Jun;25(3):215-22
pubmed: 22360543
Am J Cardiol. 2011 Aug 1;108(3):355-9
pubmed: 21545992
Am J Cardiol. 2015 Jul 15;116(2):174-86
pubmed: 25983123
J Interv Cardiol. 2018 Apr;31(2):129-135
pubmed: 29148142
Heart. 2013 May;99(10):690-9
pubmed: 23539556
Int J Cardiol. 2004 Oct;97(1):73-6
pubmed: 15336810
Catheter Cardiovasc Interv. 2009 Feb 15;73(3):301-7
pubmed: 19213083
Eur Heart J. 2009 Oct;30(19):2308-17
pubmed: 19720640
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2401-2410
pubmed: 29217002
JACC Cardiovasc Interv. 2011 Jun;4(6):618-26
pubmed: 21700247
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):333-40
pubmed: 22936604
J Am Coll Cardiol. 1985 Mar;5(3):587-92
pubmed: 3156171

Auteurs

Cãlin Homorodean (C)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Emergency County Hospital, Cluj-Napoca, Romania.

Adrian Corneliu Iancu (AC)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Niculae Stãncioiu" Heart Institute, Cluj-Napoca, Romania.

Daniel Leucuţa (D)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Şerban Bãlãnescu (Ş)

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Ioana Mihaela Dregoesc (IM)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Niculae Stãncioiu" Heart Institute, Cluj-Napoca, Romania.

Mihai Spînu (M)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Mihai Ober (M)

Emergency County Hospital, Cluj-Napoca, Romania.

Dan Tãtaru (D)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Emergency County Hospital, Cluj-Napoca, Romania.

Maria Olinic (M)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Emergency County Hospital, Cluj-Napoca, Romania.

Dan Bindea (D)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Niculae Stãncioiu" Heart Institute, Cluj-Napoca, Romania.

Dan Olinic (D)

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Emergency County Hospital, Cluj-Napoca, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH